The company signed 3 more contracts this quarter for contract manufacturing with international companies, taking the cumulative number of contracts signed to 17 with peak revenue potential of US $25.5 million.
During the quarter, the company launched Novolizer, a device for Asthma and COPD. Meda Pharma of Sweden has provided the technology for the device alongwith exclusive rights to manufacture and market Novolizer in India.
|
Budget: 2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget | Budget 2012
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide | History India
| Up Polls | Latest News
| Uninor | Namma Metro | LIC Housing Finance | Tata Steel | Reliance Industries | Mahindra Satyam | BSE Sensex | Aurobindo Pharma | Montek Singh Ahluwalia | Iran 
